glp 1 agonist risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists The promise and peril of
Description
Recurrent nocturnal hypoxic episodes promote oxidative stress and inflammatory activation, characterized by elevated TNF- , IL-6, and C-reactive protein levels (35)
C., & La Fleur, S
Understanding what these transitions look like reinforces the distinction between insulin and GLP-1 medications
Int J Obes (Lond) 2024;48(8):11181125
